CH502981A - Verfahren zur Herstellung neuer Salicylsäure-Verbindungen - Google Patents

Verfahren zur Herstellung neuer Salicylsäure-Verbindungen

Info

Publication number
CH502981A
CH502981A CH1494368A CH1494368DA CH502981A CH 502981 A CH502981 A CH 502981A CH 1494368 A CH1494368 A CH 1494368A CH 1494368D A CH1494368D A CH 1494368DA CH 502981 A CH502981 A CH 502981A
Authority
CH
Switzerland
Prior art keywords
production
salicylic acid
acid compounds
new salicylic
new
Prior art date
Application number
CH1494368A
Other languages
English (en)
Inventor
Hastings Sarett Lewis
Vance Ruyle William
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH502981A publication Critical patent/CH502981A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH1494368A 1967-10-06 1968-10-07 Verfahren zur Herstellung neuer Salicylsäure-Verbindungen CH502981A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67327367A 1967-10-06 1967-10-06

Publications (1)

Publication Number Publication Date
CH502981A true CH502981A (de) 1971-02-15

Family

ID=24701969

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1494368A CH502981A (de) 1967-10-06 1968-10-07 Verfahren zur Herstellung neuer Salicylsäure-Verbindungen

Country Status (7)

Country Link
US (1) US3558641A (de)
BR (1) BR6802728D0 (de)
CH (1) CH502981A (de)
DE (1) DE1801303A1 (de)
FR (1) FR1585315A (de)
GB (1) GB1214079A (de)
NL (1) NL161759C (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993763A (en) * 1969-03-18 1976-11-23 Ciba-Geigy Corporation Tertiary aminoacids as anti-inflammatory agents
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
US3676451A (en) * 1970-06-09 1972-07-11 Merck & Co Inc Thiazolylsalicylic acids
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
US3929833A (en) * 1970-10-30 1975-12-30 Sandoz Ag Organic compounds
FR2128285A1 (en) * 1971-03-11 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive mao-inhibitory, anticonvulsant antiinflammatory choleretic and antiviral activity prepn
FR2128292A1 (en) * 1971-03-12 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive, mao-inhibitory, anticonvulsant antiinflammatory, choleretic and antiviral activity prepn
US3860640A (en) * 1972-04-12 1975-01-14 Nippon Shinyaku Co Ltd 3-alkoxy-5-substituted phenylacetic acids
US3865839A (en) * 1973-03-01 1975-02-11 Hoechst Co American Thiopyranopyrrolylsalicyclic acids and derivatives thereof
US4111935A (en) * 1975-01-02 1978-09-05 Smith Kline & French Laboratories Limited 3-chloro-6-phenylpyridazine compounds
US4152341A (en) * 1975-12-29 1979-05-01 Imperial Chemical Industries Limited Triaryl or diarylpyridyl methanes
GB1560880A (en) * 1975-12-29 1980-02-13 Ici Ltd Diphenylmethane derivatives and pharmaceutical compositions containing them
DE2818765A1 (de) * 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE3668450D1 (de) * 1985-03-14 1990-03-01 Smithkline Dauelsberg 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren.
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
ES2639863B1 (es) * 2017-03-10 2018-09-20 Universidad De Granada Compuestos para el tratamiento de enfermedades causadas por la acumulación de oxalato

Also Published As

Publication number Publication date
NL161759C (nl) 1980-03-17
GB1214079A (en) 1970-12-02
NL161759B (nl) 1979-10-15
FR1585315A (de) 1970-01-16
DE1801303A1 (de) 1969-06-19
US3558641A (en) 1971-01-26
BR6802728D0 (pt) 1973-05-10
NL6813639A (de) 1969-04-09

Similar Documents

Publication Publication Date Title
CH513111A (de) Verfahren zur Herstellung neuer Benz-epinderivate
CH502981A (de) Verfahren zur Herstellung neuer Salicylsäure-Verbindungen
AT293633B (de) Verfahren zur Herstellung neuer Halogenpregnadiene
CH536278A (de) Verfahren zur Herstellung neuer substituierter Salicylsäuren
AT282575B (de) Verfahren zur Herstellung neuer Methylen-bis-thiolsulfonsäureester
CH526579A (de) Verfahren zur Herstellung neuer Benziodoxanderivate
CH501013A (de) Verfahren zur Herstellung neuer Phosphonsäureester
CH513129A (de) Verfahren zur Herstellung neuer Biphenylverbindungen
AT294854B (de) Verfahren zur Herstellung neuer D-Glucofuranoside
CH514581A (de) Verfahren zur Herstellung neuer Essigsäure-Derivate
CH532558A (de) Verfahren zur Herstellung von Naphthalindisulfonsäure
CH500935A (de) Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen
CH517736A (de) Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate
CH510660A (de) Verfahren zur Herstellung neuer Glucofuranoside
AT292729B (de) Verfahren zur Herstellung neuer basischer Organozinnverbindungen
AT286969B (de) Verfahren zur Herstellung neuer schwefelhaltiger Oxalsäure-di-anilide
CH522682A (de) Verfahren zur Herstellung von Phosphorverbindungen
CH532562A (de) Verfahren zur Herstellung neuer 3-Oxo-A-nor-B-homo-pregnatriene
CH491110A (de) Verfahren zur Herstellung neuer Cassensäure-Derivate
CH491084A (de) Verfahren zur Herstellung neuer Cassensäure-Derivate
CH504400A (de) Verfahren zur Herstellung von Phenylsalicylsäure
CH509987A (de) Verfahren zur Herstellung neuer Benzolsulfonamide
CH502980A (de) Verfahren zur Herstellung neuer Biphenylverbindungen
AT284790B (de) Verfahren zur Herstellung von komplexen basischen Bleiverbindungen
AT286511B (de) Verfahren zur Herstellung neuer 4-Imino-19-nor-A-homo-steroid-triene

Legal Events

Date Code Title Description
PL Patent ceased